vaccine

London's Telegraph reports that results from a Phase 1 clinical trial evaluating Oxford University's COVID-19 vaccine candidate ChAdOx1 nCoV-19 [ADZ1222 by licensee AstraZeneca (NYSE:AZN)] in healthy volunteers showed that it triggered a "double defense" immune response against the SARS-CoV-2 virus. Researchers noted that administration of the candidate produced both antibodies and killer T cells. The…

By Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Scientist Xinhua Yan works in the lab at Moderna in Cambridge, MA.David L. Ryan/The Boston Globe via Getty Images Latest coronavirus news as of 5 pm on 15 July Moderna coronavirus vaccine candidate deemed safe in first human trial A…

ISSAM AHMED, AFP 15 JULY 2020 The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal. The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the…

The first coronavirus vaccine to be tested in the U.S. boosted the immune systems of the study's participants and is being hailed a major step in the right direction towards eradicating COVID-19.“No matter how you slice this, this is good news,” Dr. Anthony Fauci told The Associated Press.The vaccine, which was developed by researchers at the National…

This story has a long way to go before being over. The story of the tortoise and the hare ranks as one of the most beloved of Aesop's fables. In this fable, the hare gets out to a commanding head start in a race. But the slow-and-steady tortoise ultimately wins. We're seeing a different kind…